Mark Meerson

455 total citations
5 papers, 160 citations indexed

About

Mark Meerson is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Mark Meerson has authored 5 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Physiology and 1 paper in Pharmacology. Recurrent topics in Mark Meerson's work include Telomeres, Telomerase, and Senescence (2 papers), CRISPR and Genetic Engineering (2 papers) and RNA Interference and Gene Delivery (1 paper). Mark Meerson is often cited by papers focused on Telomeres, Telomerase, and Senescence (2 papers), CRISPR and Genetic Engineering (2 papers) and RNA Interference and Gene Delivery (1 paper). Mark Meerson collaborates with scholars based in Russia and United States. Mark Meerson's co-authors include Vadim N. Gladyshev, Aleksandra S. Anisimova, Ivan V. Kulakovskiy, Maxim V. Gerashchenko, Sergey E. Dmitriev, Maria P. Rubtsova, О. А. Донцова, Alexey V. Beletsky, Nikolai V. Ravin and Timofei S. Zatsepin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Mark Meerson

4 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Meerson Russia	4	121	48	21	19	12	5	160
Suam Gonzalez United Kingdom	4	116 1.0×	17 0.4×	47 2.2×	13 0.7×	20 1.7×	4	160
Clara Lopes Novo United Kingdom	9	275 2.3×	84 1.8×	19 0.9×	23 1.2×	7 0.6×	14	316
Jennifer J. McCann United States	5	90 0.7×	25 0.5×	13 0.6×	30 1.6×	7 0.6×	8	167
Julien Delafontaine Switzerland	2	217 1.8×	119 2.5×	24 1.1×	34 1.8×	7 0.6×	2	260
Fabián Morales-Polanco United States	5	225 1.9×	17 0.4×	21 1.0×	13 0.7×	37 3.1×	9	274
Allison Chen United States	4	120 1.0×	24 0.5×	18 0.9×	5 0.3×	33 2.8×	4	159
Chen Lesnik Israel	6	272 2.2×	14 0.3×	31 1.5×	15 0.8×	31 2.6×	7	306
Aditi Trehan United States	5	108 0.9×	18 0.4×	4 0.2×	20 1.1×	8 0.7×	6	150
Ashfaq Ali Mir Germany	5	123 1.0×	41 0.9×	5 0.2×	15 0.8×	12 1.0×	5	194
Gergana Shipkovenska United States	5	341 2.8×	28 0.6×	8 0.4×	23 1.2×	29 2.4×	5	356

Countries citing papers authored by Mark Meerson

Since Specialization

Citations

This map shows the geographic impact of Mark Meerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Meerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Meerson more than expected).

Fields of papers citing papers by Mark Meerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Meerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Meerson. The network helps show where Mark Meerson may publish in the future.

Co-authorship network of co-authors of Mark Meerson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Meerson. A scholar is included among the top collaborators of Mark Meerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Meerson. Mark Meerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Almog, Nava, Nikita Kotlov, Mark Meerson, et al.. (2022). Integrated Genomic and Transcriptomic Analysis Provides Molecular Characterization of Distinct Clonal Evolution Pathways during Follicular Lymphoma Transformation. Blood. 140(Supplement 1). 6681–6682.

2.

Stepanov, Alexander A., et al.. (2021). Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer’s Disease Platform. CPT Pharmacometrics & Systems Pharmacology. 10(6). 543–550. 7 indexed citations

3.

Anisimova, Aleksandra S., Mark Meerson, Maxim V. Gerashchenko, et al.. (2020). Multifaceted deregulation of gene expression and protein synthesis with age. Proceedings of the National Academy of Sciences. 117(27). 15581–15590. 80 indexed citations

4.

Rubtsova, Maria P., Mark Meerson, Timofei S. Zatsepin, et al.. (2019). Integrator is a key component of human telomerase RNA biogenesis. Scientific Reports. 9(1). 1701–1701. 36 indexed citations

5.

Rubtsova, Maria P., Mark Meerson, Maria I. Zvereva, et al.. (2018). Protein encoded in human telomerase RNA is involved in cell protective pathways. Nucleic Acids Research. 46(17). 8966–8977. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact